| Literature DB >> 36051354 |
Chau Duc Nguyen-Huu1, Son Bui-Binh-Bao1, Kiem Hao Tran2, Van Tuan Mai3, Diem Chi Nguyen-Thi2, Hanh Chan Tran-Thi2, Anh Nguyen-Duy-Nam1, Phuc To1, Van Anh Ton-Nu1.
Abstract
Objective: Our study aimed to summarize symptoms and laboratory findings of bacterial meningitis at a Vietnam tertiary care hospital.Entities:
Keywords: S. pneumonia; Vietnam; bacterial meningitis; cerebrospinal fluid
Year: 2022 PMID: 36051354 PMCID: PMC9427117 DOI: 10.2147/PHMT.S371914
Source DB: PubMed Journal: Pediatric Health Med Ther ISSN: 1179-9927
The Demographic Characteristic of Study Participants
| Variables | Total (n=33) | Outcome | P value | |
|---|---|---|---|---|
| Alive (n=29) | Death (n=4) | |||
| Age group | >0.05 | |||
| <1 | 3 (9.1%) | 2 (6.9%) | 1 (25%) | |
| 1–5 | 20 (60.6%) | 17 (58.6%) | 3 (75%) | |
| >5 | 10 (30.3%) | 10 (34.5%) | 0 (0%) | |
| Gender | >0.05 | |||
| Female | 13 (39.4%) | 12 (41.4%) | 1 (25%) | |
| Male | 20 (60.6%) | 17 (58.6%) | 3 (75%) | |
| Location | >0.05 | |||
| Rural | 24 (72.7%) | 22 (75.9%) | 2 (50%) | |
| Urban | 9 (27.3%) | 7 (24.1%) | 2 (50%) | |
| Headache | 8 (24.2%) | 7 (24.1%) | 1 (25%) | >0.05 |
| Fever | 26 (78.8%) | 23 (79.3%) | 3 (75%) | >0.05 |
| Vomit | 13 (39.4%) | 11 (37.9%) | 2 (50%) | >0.05 |
| Seizures | 12 (36.4%) | 11 (37.9%) | 1 (25%) | >0.05 |
| Fever | 31 (93.9%) | 27 (93.1%) | 4 (100%) | >0.05 |
| Headache | 10 (30.3%) | 9 (31%) | 1 (25%) | >0.05 |
| Vomit | 20 (60.6%) | 18 (62.1%) | 2 (50%) | >0.05 |
| Large fontanelle | 7 (21.2%) | 6 (20.7%) | 1 (25%) | >0.05 |
| Neck stiffness | 14 (42.4%) | 12 (41.4%) | 2 (50%) | >0.05 |
| Loss of consciousness | 5 (15.2%) | 3 (10.3%) | 2 (50%) | <0.05 |
| Diarrhea | 7 (21.2%) | 5 (17.2%) | 2 (50%) | >0.05 |
| Constipation | 5 (15.2%) | 5 (17.2%) | 0 (0%) | >0.05 |
| Poor appetite | 16 (48.5%) | 13 (44.8%) | 3 (75%) | >0.05 |
| Seizures | 14 (42.4%) | 12 (41.4%) | 2 (50%) | >0.05 |
| Local paralysis | 5 (15.2%) | 3 (10.3%) | 2 (50%) | <0.05 |
| 8 (24.2%) | 7 (24.1%) | 1 (25%) | >0.05 | |
| 6 (75%) | 5 (17.2%) | 1 (100%) | ||
| 1 (12.5%) | 1 (100%) | 0 (0%) | ||
| 1 (12.5%) | 1 (100%) | 0 (0%) | ||
| 18 (13–25) | 18 (14–25) | 11 (9.8–17.8) | >0.05 | |
| <7 days | 1 (3%) | 1 (3.5%) | 0 (0%) | |
| 7–14 days | 11 (33.3%) | 8 (27.6%) | 3 (75%) | |
| >14 days | 21 (63.6%) | 20 (69%) | 1 (25%) | |
| 4 (12.9%) | 4 (13.8%) | - | ||
Note: *Data are median (IQR).
Laboratory Findings of Blood and Cerebrospinal Fluid (CSF)
| Variables | Total (N=33) | Outcome | P value | |
|---|---|---|---|---|
| Alive (n=29) | Death (n=4) | |||
| 15.3 (9.4–19.4) | 15.3 (9.4–19.4) | 17.8 (12.8–22.6) | >0.05 | |
| Increase (>12 x 109/ L) | 6 (18.2%) | 6 (20.7%) | 0 (0%) | |
| Decrease (<8 x 109/ L) | 20 (60.6%) | 17 (58.6%) | 3 (75%) | |
| 9.2 (5.7–13) | 9.2 (5.4–13) | 9.4 (7.9–12.5) | >0.05 | |
| Increase (>70%) | 16 (48.5%) | 15 (51.7%) | 1 (25%) | |
| 298 (218–392) | 298 (205–392) | 338.5 (282.8–449.2) | >0.05 | |
| Increase (>300 x 109/ L) | 16 (48.5%) | 14 (48.3%) | 2 (50%) | |
| Decrease (<150 x 109/ L) | 3 (9.1%) | 3 (10.3%) | 0 (0%) | |
| 56.5 (10–169.4) | 57 (11.2–176.7) | 7 (2.8–38.6) | >0.05 | |
| Increase (>10 mg/ L) | 24 (72.7%) | 22 (75.9%) | 2 (50%) | |
| 5.3 (4.2–6.6) | 5.3 (4.2–6.6) | 5.2 (4.1–8.3) | >0.05 | |
| Increase (> 7.5 mmol/L) | 5 (15.2%) | 4 (13.8%) | 1 (25%) | |
| 130 (129–134) | 130 (129–134) | 128 (125–131.7) | >0.05 | |
| Decrease (<135 mmol/L) | 26 (78.8%) | 22 (75.9%) | 4 (100%) | |
| 3.8 (3.6–4.2) | 3.8 (3.6–4.2) | 3.8 (3.7–3.8) | >0.05 | |
| Increase (>5 mmol/L) | 1 (3%) | 1 (3.5%) | 0 (0%) | |
| Decrease (<3.5 mmol/L) | 5 (15.2%) | 5 (17.2%) | 0 (0%) | |
| 98 (94–101) | 98 (94–101) | 97.5 (94–100.1) | >0.05 | |
| Increase (>105 mmol/L) | 0 | 0 | 0 | |
| Decrease (<95 mmol/L) | 10 (30.3%) | 9 (31%) | 1 (25%) | |
| >0.05 | ||||
| Cloudy | 18 (54.5%) | 13 (44.9%) | 3 (75%) | |
| Yellow | 7 (21.2%) | 6 (20.7%) | 1 (25%) | |
| Pink | 2 (6.1%) | 4 (13.8%) | 0 (0%) | |
| Transparent | 6 (18.2%) | 6 (20.7%) | 0 (0%) | |
| 480 (154–1750) | 450 (135–1130) | 2170 (1610–2800) | <0.05 | |
| 5–100 | 6 (18.2%) | 6 (20.7%) | 0 (0%) | |
| 100–500 | 11 (33.3%) | 11 (37.9%) | 0 (0%) | |
| >500 | 16 (48.5%) | 12 (41.4%) | 4 (100%) | |
| NEU (cells/mm | 198 (59.5–744) | 164.5 (59.5–744) | 466 (166.5–1062) | <0.05 |
| 2.6 (1.7–3.7) | 2.6 (1.5–3.7) | 4.6 (2.7–7.6) | >0.05 | |
| Decrease (<2.2 mmol/L) | 10 (30.3%) | 10 (34.5%) | 0 (0%) | |
| 1.5 (0.8–3.5) | 1.5 (0.9–3.4) | 3 (0.7–6) | >0.05 | |
| Increase (≥ 0.45 g/L) | 32 (97.0%) | 28 (96.6%) | 4 (100%) | |
Note: *Data are median (IQR).
Abbreviations: WBC, white blood cells; NEU, neutrophils; CRP, C-reactive protein.